R Turner Goins1, Blythe Winchester2, Luohua Jiang3, Laura Grau4, Maggie Reid4, Maria M Corrada3, Spero M Manson4, Joan O'Connell4. 1. College of Health and Human Sciences, Western Carolina University, Cullowhee, North Carolina, USA. 2. Eastern Band of Cherokee Indians, Cherokee Indian Hospital, Cherokee, North Carolina, USA. 3. Department of Epidemiology, University of California Irvine, USA. 4. Colorado School of Public Health, University of Colorado Denver, USA.
Abstract
BACKGROUND: Diabetes, hypertension, and cardiovascular disease (CVD) are modifiable lifestyle-related cardiometabolic conditions associated with dementia. Yet, little is known regarding these associations among American Indian and Alaska Native (AI/AN) people. Thus, we examined the association of diabetes, hypertension, and CVD with all-cause dementia among AI/ANs aged 65 years and older. METHOD: This was a cross-sectional analysis of the Indian Health Service Improving Health Care Delivery Data Project. Our study population was a 1:1 matched sample of 4 074 AI/ANs aged 65 years and older and Indian Health Service active users during fiscal year 2013. We employed International Classification of Diseases, Ninth Revision, Clinical Modification diagnostic codes for all-cause dementia, hypertension, and CVD. Diabetes was measured with a validated algorithm to identify adults with diabetes that uses diagnoses, laboratory test results, and medication criteria. RESULTS: Multivariable analyses revealed that diabetes and CVD were associated with increased odds of all-cause dementia and hypertension was not. Cardiovascular disease types associated with all-cause dementia differed with cerebrovascular disease having the strongest association. Analyses stratified by gender revealed that diabetes and CVD were associated with increased odds of all-cause dementia for women and only CVD was associated with all-cause dementia for men. CONCLUSIONS: Training and support of primary care clinicians, addressing cultural considerations, and ensuring inclusion of AI/ANs in research are steps that could help meet AI/AN people's needs. Our findings underscore to the importance of improved management and control of diabetes and CVD, which may lead to the prevention of dementia among older AI/ANs.
BACKGROUND: Diabetes, hypertension, and cardiovascular disease (CVD) are modifiable lifestyle-related cardiometabolic conditions associated with dementia. Yet, little is known regarding these associations among American Indian and Alaska Native (AI/AN) people. Thus, we examined the association of diabetes, hypertension, and CVD with all-cause dementia among AI/ANs aged 65 years and older. METHOD: This was a cross-sectional analysis of the Indian Health Service Improving Health Care Delivery Data Project. Our study population was a 1:1 matched sample of 4 074 AI/ANs aged 65 years and older and Indian Health Service active users during fiscal year 2013. We employed International Classification of Diseases, Ninth Revision, Clinical Modification diagnostic codes for all-cause dementia, hypertension, and CVD. Diabetes was measured with a validated algorithm to identify adults with diabetes that uses diagnoses, laboratory test results, and medication criteria. RESULTS: Multivariable analyses revealed that diabetes and CVD were associated with increased odds of all-cause dementia and hypertension was not. Cardiovascular disease types associated with all-cause dementia differed with cerebrovascular disease having the strongest association. Analyses stratified by gender revealed that diabetes and CVD were associated with increased odds of all-cause dementia for women and only CVD was associated with all-cause dementia for men. CONCLUSIONS: Training and support of primary care clinicians, addressing cultural considerations, and ensuring inclusion of AI/ANs in research are steps that could help meet AI/AN people's needs. Our findings underscore to the importance of improved management and control of diabetes and CVD, which may lead to the prevention of dementia among older AI/ANs.
Authors: Mark Veazie; Carma Ayala; Linda Schieb; Shifan Dai; Jeffrey A Henderson; Pyone Cho Journal: Am J Public Health Date: 2014-04-22 Impact factor: 9.308
Authors: María M Corrada; Kathleen M Hayden; Annlia Paganini-Hill; Szofia S Bullain; Jaime DeMoss; Colette Aguirre; Ron Brookmeyer; Claudia H Kawas Journal: Alzheimers Dement Date: 2017-01-17 Impact factor: 21.566
Authors: Norman L Foster; Mark W Bondi; Rohit Das; Mary Foss; Linda A Hershey; Steve Koh; Rebecca Logan; Carol Poole; Joseph W Shega; Ajay Sood; Niranjan Thothala; Meredith Wicklund; Melissa Yu; Amy Bennett; David Wang Journal: Neurology Date: 2019-09-18 Impact factor: 9.910
Authors: Richard A Goodman; Kimberly A Lochner; Madhav Thambisetty; Thomas S Wingo; Samuel F Posner; Shari M Ling Journal: Alzheimers Dement Date: 2016-05-10 Impact factor: 21.566
Authors: Rebecca A Nebel; Neelum T Aggarwal; Lisa L Barnes; Aimee Gallagher; Jill M Goldstein; Kejal Kantarci; Monica P Mallampalli; Elizabeth C Mormino; Laura Scott; Wai Haung Yu; Pauline M Maki; Michelle M Mielke Journal: Alzheimers Dement Date: 2018-06-12 Impact factor: 21.566